I think NNZ2591 is worth a lot more than 1.5b at the current stage of the development. You can refer to my post here regarding a recent deal on a phase 3 ready asset for a rare disorder. It's sold for nearly $1b USD and disorder has two existing products in market. Based on this, PMS and Pitt Hopkins alone would be worth well over $2b USD given they have no competition and almost phase 3 ready.
https://hotcopper.com.au/threads/the-whens-and-whys-of-top-biotech-m-a-deals.8141625/
Share Price, page-11421
-
- There are more pages in this discussion • 1,340 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.35 |
Change
0.070(0.57%) |
Mkt cap ! $1.578B | |||
| Open | High | Low | Value | Volume |
| $12.25 | $12.45 | $12.02 | $7.808M | 638.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41 | $12.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.37 | 1579 | 2 |
View Market Depth
| Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |